Commercial Access Only

Specimen SS-COM-BTR-0302 // BITTER

Receptor Block T1-AG-PH

Brassica napus

Canola/Rapeseed

Receptor Block SeriesTier 1

Target Trait

35

% reduction

Reported target: 35% bitter reduction

Technical Specifications

Genomic Edits

6

GC Content

(46%)

Construct Length

5,060 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Pathway Edits

  • TAS2R38 partial suppression
  • Glucosinolate pathway attenuation

Key Interventions

TAS2R38 RNAi knockdown constructSinigrin reduction via glucosinolate pathway attenuation

Application Domains

PharmaceuticalResearch

Intended Use

Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications

Access

Request Commercial Access

This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.

Contact Us →

No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.

Back to Commercial Catalog